Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Ringel

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
NPJ Digital Medicine|August 3, 2019
Artificial intelligence and machine learning in clinical development: a translational perspectivePratik Shah, Francis Kendall, Sean Khozin, et al.
Toxicology|December 14, 2004
Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine (2C-B): analysis of phase I metabolism with hepatocytes of six species including humanHelena Carmo, Jan G Hengstler, Douwe de Boer, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 17, 2003
Comparative metabolism of the designer drug 4-methylthioamphetamine by hepatocytes from man, monkey, dog, rabbit, rat and mouseHelena Carmo, Jan G Hengstler, Douwe de Boer, et al.
Plos One|December 16, 2016
Quantifying Geographic Variation in Health Care Outcomes in the United States before and after Risk-AdjustmentBarry L Rosenberg, Joshua A Kellar, Anna Labno, et al.
Drug Metabolism Reviews|September 10, 2003
New hepatocyte in vitro systems for drug metabolism: metabolic capacity and recommendations for application in basic research and drug development, standard operation proceduresRolf Gebhardt, Jan G Hengstler, Dieter Müller, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
NPJ Digital Medicine|August 3, 2019
Artificial intelligence and machine learning in clinical development: a translational perspectivePratik Shah, Francis Kendall, Sean Khozin, et al.
Toxicology|December 14, 2004
Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine (2C-B): analysis of phase I metabolism with hepatocytes of six species including humanHelena Carmo, Jan G Hengstler, Douwe de Boer, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 17, 2003
Comparative metabolism of the designer drug 4-methylthioamphetamine by hepatocytes from man, monkey, dog, rabbit, rat and mouseHelena Carmo, Jan G Hengstler, Douwe de Boer, et al.
Plos One|December 16, 2016
Quantifying Geographic Variation in Health Care Outcomes in the United States before and after Risk-AdjustmentBarry L Rosenberg, Joshua A Kellar, Anna Labno, et al.
Drug Metabolism Reviews|September 10, 2003
New hepatocyte in vitro systems for drug metabolism: metabolic capacity and recommendations for application in basic research and drug development, standard operation proceduresRolf Gebhardt, Jan G Hengstler, Dieter Müller, et al.
Pageof 2